What is MINIMED GROUP INC's earnings per share (EPS)?

MINIMED GROUP INC (MMED) reported diluted earnings per share of $-1.30 for fiscal year 2026. This represents a -54.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

MINIMED GROUP INC Financials

MMED

Source SEC Filings (10-K/10-Q) Data as of Apr 24, 2026 Currency USD FYE April

This page shows MINIMED GROUP INC (MMED) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Health Score 50/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of MINIMED GROUP INC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

MINIMED GROUP INC has an operating margin of -6.1%, meaning the company retains $-6 of operating profit per $100 of revenue. This results in a moderate score of 39/100, indicating healthy but not exceptional operating efficiency. This is down from -5.4% the prior year.

Growth

MINIMED GROUP INC's revenue grew 14.3% year-over-year to $3.1B, a solid pace of expansion. This earns a growth score of 70/100.

Leverage

MINIMED GROUP INC carries a low D/E ratio of 0.28, meaning only $0.28 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 69/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

MINIMED GROUP INC's current ratio of 1.92 indicates adequate short-term liquidity, earning a score of 55/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While MINIMED GROUP INC generated -$197.0M in operating cash flow, capex of $223.0M consumed most of it, leaving -$420.0M in free cash flow. This results in a low score of 17/100, reflecting heavy capital investment rather than weak cash generation.

Returns

MINIMED GROUP INC's ROE of -9.2% shows moderate profitability relative to equity, earning a score of 47/100. This is down from -6.0% the prior year.

Altman Z-Score Safe

3.37

MINIMED GROUP INC scores 3.37, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($4.6B) relative to total liabilities ($1.0B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

3/7

MINIMED GROUP INC passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.59x

For every $1 of reported earnings, MINIMED GROUP INC generates $0.59 in operating cash flow (-$197.0M OCF vs -$333.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.1B

YoY+14.3%

MINIMED GROUP INC generated $3.1B in revenue in fiscal year 2026. This represents an increase of 14.3% from the prior year.

EBITDA

-$34.0M

YoY-1033.3%

MINIMED GROUP INC's EBITDA was -$34.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1033.3% from the prior year.

Net Income

-$333.0M

YoY-56.3%

MINIMED GROUP INC reported -$333.0M in net income in fiscal year 2026. This represents a decrease of 56.3% from the prior year.

EPS (Diluted)

$-1.30

YoY-54.8%

MINIMED GROUP INC earned $-1.30 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 54.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$420.0M

YoY-692.5%

MINIMED GROUP INC generated -$420.0M in free cash flow in fiscal year 2026, representing cash available after capex. This represents a decrease of 692.5% from the prior year.

Cash & Debt

$298.0M

YoY+2880.0%

MINIMED GROUP INC held $298.0M in cash against $0 in long-term debt as of fiscal year 2026.

Dividends Per Share

N/A

Shares Outstanding

281M

MINIMED GROUP INC had 281M shares outstanding in fiscal year 2026.

Margins & Returns

Gross Margin

54.2%

YoY-2.1pp

MINIMED GROUP INC's gross margin was 54.2% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 2.1 percentage points from the prior year.

Operating Margin

-6.1%

YoY-0.8pp

MINIMED GROUP INC's operating margin was -6.1% in fiscal year 2026, reflecting core business profitability. This is down 0.8 percentage points from the prior year.

Net Margin

-10.7%

YoY-2.9pp

MINIMED GROUP INC's net profit margin was -10.7% in fiscal year 2026, showing the share of revenue converted to profit. This is down 2.9 percentage points from the prior year.

Return on Equity

-9.2%

YoY-3.2pp

MINIMED GROUP INC's ROE was -9.2% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is down 3.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$448.0M

YoY+2.8%

MINIMED GROUP INC invested $448.0M in research and development in fiscal year 2026. This represents an increase of 2.8% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$223.0M

YoY+15.5%

MINIMED GROUP INC invested $223.0M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 15.5% from the prior year.

MMED Income Statement

Metric	FY26	FY25	FY24
Revenue	$3.1B+14.3%	$2.7B+10.0%	$2.5B
Cost of Revenue	$1.4B+19.8%	$1.2B+15.0%	$1.0B
Gross Profit	$1.7B+9.9%	$1.5B+6.4%	$1.4B
R&D Expenses	$448.0M+2.8%	$436.0M-0.2%	$437.0M
SG&A Expenses	$1.2B+9.5%	$1.1B+2.2%	$1.1B
Operating Income	-$190.0M-30.1%	-$146.0M-111.6%	-$69.0M
Interest Expense	N/A	N/A	N/A
Income Tax	$128.0M+146.2%	$52.0M+36.8%	$38.0M
Net Income	-$333.0M-56.3%	-$213.0M-90.2%	-$112.0M
EPS (Diluted)	$-1.30-54.8%	$-0.84-90.9%	$-0.44

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Revenue	N/A	$790.0M	N/A	N/A	N/A	$687.0M	N/A	N/A
Cost of Revenue	N/A	$428.0M	N/A	N/A	N/A	$292.0M	N/A	N/A
Gross Profit	N/A	$362.0M	N/A	N/A	N/A	$395.0M	N/A	N/A
R&D Expenses	N/A	$114.0M	N/A	N/A	N/A	$112.0M	N/A	N/A
SG&A Expenses	N/A	$309.0M	N/A	N/A	N/A	$268.0M	N/A	N/A
Operating Income	N/A	-$100.0M	N/A	N/A	N/A	$21.0M	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	$12.0M	N/A	N/A	N/A	$28.0M	N/A	N/A
Net Income	N/A	-$119.0M-2280.0%	-$5.0M+68.8%	-$16.0M	N/A	-$10.0M-100.0%	-$5.0M+73.7%	-$19.0M
EPS (Diluted)	N/A	$-0.47	N/A	N/A	N/A	$-0.04	N/A	N/A

MMED Balance Sheet

Metric	FY26	FY25	FY24
Total Assets	$4.6B+6.6%	$4.3B	N/A
Current Assets	$1.3B+21.7%	$1.1B	N/A
Cash & Equivalents	$298.0M+2880.0%	$10.0M-81.5%	$54.0M
Inventory	$341.0M-16.4%	$408.0M	N/A
Accounts Receivable	$200.0M-69.4%	$653.0M	N/A
Goodwill	$2.3B0.0%	$2.3B	N/A
Total Liabilities	$1.0B+15.7%	$881.0M	N/A
Current Liabilities	$702.0M+0.9%	$696.0M	N/A
Long-Term Debt	N/A	N/A	N/A
Total Equity	$3.6B+2.1%	$3.5B+1.6%	$3.5B
Retained Earnings	-$116.0M	N/A	N/A

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Total Assets	$4.6B+6.6%	$4.3B	N/A	N/A	$4.2B	N/A	N/A	N/A
Current Assets	$1.3B+21.7%	$1.1B	N/A	N/A	$939.0M	N/A	N/A	N/A
Cash & Equivalents	$298.0M+2880.0%	$10.0M	N/A	N/A	$11.0M+10.0%	$10.0M	N/A	N/A
Inventory	$341.0M-16.4%	$408.0M	N/A	N/A	$311.0M	N/A	N/A	N/A
Accounts Receivable	$200.0M-69.4%	$653.0M	N/A	N/A	$570.0M	N/A	N/A	N/A
Goodwill	$2.3B0.0%	$2.3B	N/A	N/A	$2.3B	N/A	N/A	N/A
Total Liabilities	$1.0B+15.7%	$881.0M	N/A	N/A	$871.0M	N/A	N/A	N/A
Current Liabilities	$702.0M+0.9%	$696.0M	N/A	N/A	$710.0M	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$3.6B+4.3%	$3.5B-2.8%	$3.6B+0.7%	$3.5B+6.2%	$3.3B-4.4%	$3.5B+0.7%	$3.5B-0.6%	$3.5B
Retained Earnings	-$116.0M	N/A	N/A	N/A	$0	N/A	N/A	N/A

MMED Cash Flow Statement

Metric	FY26	FY25	FY24
Operating Cash Flow	-$197.0M-240.7%	$140.0M+241.5%	$41.0M
Capital Expenditures	$223.0M+15.5%	$193.0M+30.4%	$148.0M
Free Cash Flow	-$420.0M-692.5%	-$53.0M+50.5%	-$107.0M
Investing Cash Flow	-$233.0M-20.7%	-$193.0M-22.9%	-$157.0M
Financing Cash Flow	$716.0M+7060.0%	$10.0M-91.1%	$112.0M
Dividends Paid	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Operating Cash Flow	-$170.0M	N/A	N/A	N/A	$83.0M	N/A	N/A	N/A
Capital Expenditures	$56.0M	N/A	N/A	N/A	$57.0M	N/A	N/A	N/A
Free Cash Flow	-$226.0M	N/A	N/A	N/A	$26.0M	N/A	N/A	N/A
Investing Cash Flow	-$56.0M	N/A	N/A	N/A	-$57.0M	N/A	N/A	N/A
Financing Cash Flow	$512.0M	N/A	N/A	N/A	-$25.0M	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

MMED Financial Ratios

Metric	FY26	FY25	FY24
Gross Margin	54.2%-2.1pp	56.3%-1.9pp	58.2%
Operating Margin	-6.1%-0.8pp	-5.4%-2.6pp	-2.8%
Net Margin	-10.7%-2.9pp	-7.8%-3.3pp	-4.5%
Return on Equity	-9.2%-3.2pp	-6.0%-2.8pp	-3.2%
Return on Assets	-7.2%-2.3pp	-4.9%	N/A
Current Ratio	1.92+0.3	1.59	N/A
Debt-to-Equity	0.28+0.0	0.25	N/A
FCF Margin	-13.5%-11.6pp	-1.9%+2.4pp	-4.3%

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Gross Margin	N/A	45.8%	N/A	N/A	N/A	57.5%	N/A	N/A
Operating Margin	N/A	-12.7%	N/A	N/A	N/A	3.1%	N/A	N/A
Net Margin	N/A	-15.1%	N/A	N/A	N/A	-1.5%	N/A	N/A
Return on Equity	N/A	-3.4%-3.3pp	-0.1%+0.3pp	-0.4%	N/A	-0.3%-0.1pp	-0.1%+0.4pp	-0.5%
Return on Assets	N/A	-2.7%	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	1.92+0.3	1.59	N/A	N/A	1.32	N/A	N/A	N/A
Debt-to-Equity	0.28+0.0	0.25	N/A	N/A	0.26	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

What is MINIMED GROUP INC's annual revenue?

MINIMED GROUP INC (MMED) reported $3.1B in total revenue for fiscal year 2026. This represents a 14.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is MINIMED GROUP INC's revenue growing?

MINIMED GROUP INC (MMED) revenue grew by 14.3% year-over-year, from $2.7B to $3.1B in fiscal year 2026.

Is MINIMED GROUP INC profitable?

No, MINIMED GROUP INC (MMED) reported a net income of -$333.0M in fiscal year 2026, with a net profit margin of -10.7%.

What is MINIMED GROUP INC's EBITDA?

MINIMED GROUP INC (MMED) had EBITDA of -$34.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

What is MINIMED GROUP INC's gross margin?

MINIMED GROUP INC (MMED) had a gross margin of 54.2% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is MINIMED GROUP INC's operating margin?

MINIMED GROUP INC (MMED) had an operating margin of -6.1% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is MINIMED GROUP INC's net profit margin?

MINIMED GROUP INC (MMED) had a net profit margin of -10.7% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is MINIMED GROUP INC's return on equity (ROE)?

MINIMED GROUP INC (MMED) has a return on equity of -9.2% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is MINIMED GROUP INC's free cash flow?

MINIMED GROUP INC (MMED) generated -$420.0M in free cash flow during fiscal year 2026. This represents a -692.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is MINIMED GROUP INC's operating cash flow?

MINIMED GROUP INC (MMED) generated -$197.0M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are MINIMED GROUP INC's total assets?

MINIMED GROUP INC (MMED) had $4.6B in total assets as of fiscal year 2026, including both current and long-term assets.

What are MINIMED GROUP INC's capital expenditures?

MINIMED GROUP INC (MMED) invested $223.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does MINIMED GROUP INC spend on research and development?

MINIMED GROUP INC (MMED) invested $448.0M in research and development during fiscal year 2026.

How many shares does MINIMED GROUP INC have outstanding?

MINIMED GROUP INC (MMED) had 281M shares outstanding as of fiscal year 2026.

What is MINIMED GROUP INC's current ratio?

MINIMED GROUP INC (MMED) had a current ratio of 1.92 as of fiscal year 2026, which is generally considered healthy.

What is MINIMED GROUP INC's debt-to-equity ratio?

MINIMED GROUP INC (MMED) had a debt-to-equity ratio of 0.28 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is MINIMED GROUP INC's return on assets (ROA)?

MINIMED GROUP INC (MMED) had a return on assets of -7.2% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is MINIMED GROUP INC's cash runway?

Based on fiscal year 2026 data, MINIMED GROUP INC (MMED) had $298.0M in cash against an annual operating cash burn of $197.0M. This gives an estimated cash runway of approximately 18 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is MINIMED GROUP INC's Altman Z-Score?

MINIMED GROUP INC (MMED) has an Altman Z-Score of 3.37, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is MINIMED GROUP INC's Piotroski F-Score?

MINIMED GROUP INC (MMED) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are MINIMED GROUP INC's earnings high quality?

MINIMED GROUP INC (MMED) has an earnings quality ratio of 0.59x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is MINIMED GROUP INC?

MINIMED GROUP INC (MMED) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.